The OECD is undertaking an international stakeholder dialogue to improve patient access to innovative pharmaceutical treatments and ensure the sustainability of health spending as well as continued innovation that meets patient needs. In this capacity, the OECD is inviting submissions to identify issues with the current system, to understand which topics are of most importance to stakeholders, and to canvass new ideas. Submissions will be used to inform the synthesis of evidence and develop recommendations for governments of OECD Member countries. Contributions are sought from all sectors and stakeholders until 1 May. Both individuals and organisations are encouraged to submit. Contributions are not limited to any specific set of countries. Contributors may reflect on a country specific, regional and/or international perspective. Visit http://www.oecd.org/els/health-systems/Sustainable-access-to-innovative-therapies-Onlineconsultation.htm for details on the process.
The OECD is also holding a consultation meeting for civil society to contribute their views on sustainable access to innovative therapies in Paris on 20 June 2017.
To register your interest in attending the consultation meeting, please email: firstname.lastname@example.org. There are limited spaces available. You will be contacted before the event to confirm your place and details of the venue.
OrphaNews April 21, 2017